CHF Solutions Revenue and Competitors
Estimated Revenue & Valuation
- CHF Solutions's estimated annual revenue is currently $5.5M per year.
- CHF Solutions received $5.4M in venture funding in July 2018.
- CHF Solutions's estimated revenue per employee is $100,000
- CHF Solutions's total funding is $22.9M.
- CHF Solutions's current valuation is $6.
Employee Data
- CHF Solutions has 55 Employees.
- CHF Solutions grew their employee count by -13% last year.
CHF Solutions's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Sr. VP Human Resources | Reveal Email/Phone |
3 | VP International Business Development | Reveal Email/Phone |
4 | President & Chief Operating Officer | Reveal Email/Phone |
5 | Chief Technology Officer | Reveal Email/Phone |
6 | Product Marketing Manager | Reveal Email/Phone |
7 | Product Development Engineering Manager | Reveal Email/Phone |
8 | Corporate Controller | Reveal Email/Phone |
9 | Senior Manufacturing Engineer | Reveal Email/Phone |
10 | Marketing Communications Specialist | Reveal Email/Phone |
CHF Solutions Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $30.6M | 122 | 4% | N/A | N/A |
#2 | $18.6M | 74 | 35% | N/A | N/A |
#3 | $75.6M | 301 | 20% | N/A | N/A |
#4 | $12M | 48 | 4% | N/A | N/A |
#5 | $2.8M | 11 | 10% | N/A | N/A |
#6 | $3M | 12 | 0% | N/A | N/A |
#7 | $24.6M | 98 | 5% | N/A | N/A |
#8 | $11.5M | 46 | 21% | N/A | N/A |
#9 | $7.3M | 29 | 4% | N/A | N/A |
#10 | $13.8M | 55 | -10% | N/A | N/A |
What Is CHF Solutions?
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly-owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.
keywords:Healthcare,Healthcare Providers,Pharmaceuticals
$22.9M
Total Funding
55
Number of Employees
$5.5M
Revenue (est)
-13%
Employee Growth %
$6
Valuation
N/A
Accelerator
CHF Solutions News
When that company was acquired, then I came to CHF Solutions at that time, that was the name of it. And looking for not necessarily any...
It operates through Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS), and Other segments. The AES segment offers...
The CGS BlueCherry Enterprise Suite provides clients with comprehensive digital supply chain management solutions, available both in the...
CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company's Board of Directors ...
Other Companies in Eden Prairie
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 55 | 20% | N/A |
#2 | N/A | 55 | 2% | N/A |
#3 | $8.1M | 55 | -8% | N/A |
#4 | $13.6M | 56 | 8% | N/A |
#5 | $13M | 57 | 0% | N/A |
CHF Solutions Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2011-07-26 | $4.6M | Undisclosed | Summer Street Research Partner | Article |
| 2011-09-22 | $7.4M | Undisclosed | Street Research Partners | Article |
| 2013-04-12 | $13.1M | Undisclosed | Canaccord Genuity | Article |
| 2015-02-20 | $10.0M | Undisclosed | Silicon Valley Bank | Article |
| 2016-07-25 | $3.5M | Undisclosed | Article | |
| 2017-04-26 | $9.2M | Undisclosed | Ladenburg Thalmann & Co | Article |
| 2018-07-05 | $5.4M | Undisclosed | Ladenburg Thalmann & Co | Article |